INTRODUCING CHAI-2: ZERO-SHOT ANTIBODY DESIGN IN A 24-WELL PLATE

Summary from the TLDR AI newsletter

Finding antibodies that bind to disease targets usually means screening massive libraries for months—most pharmaceutical discovery is basically a numbers game. Chai Discovery's AI cuts straight to viable drug candidates by designing them computationally, hitting 16% success rates and finding working antibodies for 50% of targets with just 20 attempts each.